SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-00-007665
Filing Date
2000-08-14
Accepted
2000-08-14 00:00:00
Documents
3
Period of Report
2000-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT e10-q.txt 10-Q 69914
2 NON-EXCLUSIVE CROSS LICENSE AGREEMENT ex10-1.txt EX-10.1 32953
3 FINANCIAL DATA SCHEDULE ex27.txt EX-27 2133
  Complete submission text file 0000950123-00-007665.txt   106948
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 701316
SIC: 2835 In Vitro & In Vivo Diagnostic Substances